It seems that FLG, FLG2, RPTN and SPRR1A are the true key players in CTCL skin barrier deficiency, as levels of their transcripts differed significantly in comparison to healthy controls. This evidence concerns the gene RPTN and primary cutaneous T-cell non-Hodgkin lymphoma.